Publications by authors named "Richard Kerenski"
Can J Cardiol
November 2006
Article Synopsis
- Heparin combined with GP IIb/IIIa inhibitors is effective for acute coronary syndrome (ACS) patients undergoing PCI, but bivalirudin has emerged as a strong alternative.
- In a study of 891 PCI patients with ACS, those on bivalirudin experienced better angiographic outcomes compared to those on heparin, despite fewer using adjunctive inhibitors.
- No significant differences in bleeding events or major adverse cardiac events were noted between the two groups, suggesting that bivalirudin could be as effective and safe as heparin in this high-risk setting.
